Insmed Newsroom

Mizuho Securities Maintains Insmed(INSM.US) With Buy Rating, Announces Target Price $88

Futu NewsJan 22 19:33

Truist Financial Maintains Insmed(INSM.US) With Buy Rating, Announces Target Price $105

Futu NewsJan 22 06:31

TD Cowen Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $98

Futu NewsJan 21 23:31

Optimistic Buy Rating for Insmed Driven by Promising Drug Launch and Strategic Positioning

TipRanksJan 21 09:30

Truist Financial Maintains Insmed(INSM.US) With Buy Rating

Futu NewsJan 17 20:33

Analysts Are Bullish on These Healthcare Stocks: UnitedHealth (UNH), Insmed (INSM)

TipRanksJan 17 20:26

BofA Securities Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $90

Futu NewsJan 16 19:31

Analysts Offer Insights on Healthcare Companies: Insmed (INSM), Gilead Sciences (GILD) and Abbott Laboratories (ABT)

TipRanksJan 16 19:11

BofA Securities Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $90

Futu NewsJan 14 19:34

Evercore Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $75

Futu NewsJan 13 22:31

Insmed (INSM) Gets a Buy From Evercore ISI

TipRanksJan 13 21:38

Truist Financial Maintains Insmed(INSM.US) With Buy Rating

Futu NewsJan 13 21:31

Wells Fargo Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $85

Futu NewsJan 11 23:31

TD Cowen Maintains Insmed(INSM.US) With Buy Rating

Futu NewsJan 11 07:32

TD Cowen Reaffirms Their Buy Rating on Insmed (INSM)

TipRanksJan 11 06:58

BofA Securities Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $90

Futu NewsJan 6 19:31

Insmed Is Maintained at Overweight by JP Morgan

Dow JonesNov 22, 2024 23:02

Insmed Analyst Ratings

BenzingaNov 22, 2024 22:52

J.P. Morgan Maintains Insmed(INSM.US) With Buy Rating, Raises Target Price to $83

Futu NewsNov 22, 2024 19:32

BofA Securities Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $90

Futu NewsNov 21, 2024 18:32